Chemotherapy Regimens

Below is a list of common chemotherapy regimens in alphabetical order:

ABVD:

Doxorubicin (Adriamycin), Bleomycin, Vinblastine, Dacarbazine

• Hodgkin lymphoma

AC:

Doxorubicin (Adriamycin), Cyclophosphamide

• Breast cancer

AD:

Doxorubicin (Adriamycin), Dacarbazine

• Soft tissue sarcoma (esp leiomyosarcoma)

AIM:

Doxorubicin (Adriamycin), Ifosfamide, Mesna

• Soft tissue sarcoma

BEP: 

Bleomycin + Etoposide + Cisplatin

• Testicular cancer

• Ovarian malignant germ cell tumors

BR:

Bendamustine + Rituximab

• CLL

BrECADD:

Brentuximab vedotin, Etoposide, Cyclophosphamide, Doxorubicin (Adriamycin), Dacarbazine, Dexamethasone

• Hodgkin lymphoma

BV-AVD:

Brentuximab Vedotin, Doxorubicin (Adriamycin), Vinblastine, Dacarbazine

• Hodgkin lymphoma

BV-CHP:

Brentuximab Vedotin, Cyclophosphamide, Hydroxydaunorubicin (Doxorubicin), Prednisone

• CD30-positive peripheral T-cell lymphomas

CAPOX:

Capecitabine, Oxaliplatin

• GI cancers

CMF:

Cyclophosphamide, Methotrexate, 5-Fluorouracil

• Breast cancer

DA-EPOCH-R (dose adjusted R-EPOCH):

Dose Adjusted Etoposide, Prednisone, Vincristine (Oncovin), Cyclophosphamide, Hydroxydaunorubicin (Doxorubicin), Rituximab

• DLBCL

DCF:

Docetaxel, Cisplatin, 5-Fluorouracil

• Esophageal/ GEJ cancer

• Gastric cancer

• Head and neck cancer

• Anal SCC

DDGP:

Dexamethasone, Cisplatin (DDP), Gemcitabine, Pegaspargase

• Extranodal NK/T-cell lymphoma (ENKTL)

ddMVAC:

dose-dense Methotrexate, Vinblastine, Doxorubicin, Cisplatin

• Muscle invasive bladder cancer

DeVIC:

Dexamethasone, Etoposide (VP-16), Ifosfamide, Carboplatin

• Extranodal NK/T-cell lymphoma (ENKTL)

DHAP:

Dexamethasone, High-dose cytarabine (Ara-C), Cisplatin

• Hodgkin lymphoma

EC:

Epirubicin, Cyclophosphamide

• Breast cancer

EP:

Etoposide, Cisplatin

• Small cell lung cancer

• Germinal cell testicular cancer (If BEP is contraindicated)

FLOT:

Fluorouracil (5-FU), Leucovorin (Folinic acid), Oxaliplatin, Docetaxel

• Esophageal and EGJ cancers

• Gastric cancers

FOLFCIS:

Leucovorin (Folinic acid), Fluorouracil (5-FU), Cisplatin

• Anal SCC

FOLFIRI:

Leucovorin (Folinic acid), Fluorouracil (5-FU), Irinotecan

• GI cancers

FOLFIRINOX:

Leucovorin (Folinic acid), Fluorouracil (5-FU), Irinotecan, Oxaliplatin

• GI cancers

FOLFOX:

Leucovorin (Folinic acid), Fluorouracil (5-FU), Oxaliplatin

• GI cancers

FRC:

Fludarabine + Rituximab + Cyclophosphamide

• CLL

GDP:

Gemcitabine, Dexamethasone, Cisplatin/Carboplatin

• DLBCL

GELAD:

Gemcitabine, Etoposide, Pegaspargase (a form of L-asparaginase), Dexamethasone

• Extranodal NK/T-cell lymphoma (ENKTL)

GVD:

Gemcitabine, Vinorelbine, Liposomal Doxorubicin

• Hodgkin lymphoma

ICE

Ifosfamide, Carboplatin, Etoposide

• Hodgkin lymphoma

• DLBCL

MAP:

Methotrexate, Doxorubicin (Adriamycin), Cisplatin

• Osteosarcoma

• Urothelial (bladder) carcinoma

NALIRIFOX:

NanoLiposomal Irinotecan, Fluorouracil (5-FU), Oxaliplatin

• Pancreatic adenocarcinoma

P-GEMOX:

Pegaspargase, Gemcitabine, Oxaliplatin

• Extranodal NK/T-cell lymphoma (ENKTL)

Pola-BR:

Polatuzumab vedotin, Bendamustine, Rituximab

• DLBCL

Pola-R-CHP:

Polatuzumab vedotin, Rituximab, Cyclophosphamide, Hydroxydaunorubicin (Doxorubicin), Prednisone

• DLBCL

POMP:

Mercaptopurine, Vincristine (Oncovin), Methotrexate, Prednisone

• ALL

R-CHOP:

Rituximab, Cyclophosphamide, Hydroxydaunorubicin (Doxorubicin), Vincristine (Oncovin), Prednisone

• DLBCL

R-CODOX-M/IVAC:

Rituximab, Cyclophosphamide, Vincristine (Oncovin), Doxorubicin, High-dose Methotrexate/

Ifosfamide, Etoposide (VP-16), high-dose Ara-C (Cytarabine)

• Burkitt lymphoma

R-DHAP (Rituximab + DHAP):

Rituximab, Dexamethasone, High-dose cytarabine (Ara-C), Cisplatin

• DLBCL

• Mantle Cell Lymphoma

R-EPOCH (R-CHOP + Etoposide):

Rituximab, Etoposide, Prednisone, Vincristine (Oncovin), Cyclophosphamide, Hydroxydaunorubicin (Doxorubicin)

• DLBCL

R-GDP (Rituximab + GDP):

Rituximab, Gemcitabine, Dexamethasone, Cisplatin/Carboplatin

• DLBCL

R-GemOx:

Rituximab, Gemcitabine, Oxaliplatin

• DLBCL

RICE (Rituximab + ICE):

Rituximab, Ifosfamide, Carboplatin, Etoposide

• DLBCL

SMILE:

Steroid (Dexa), Methotrexate, Ifosfamide, L-asparaginase, Etoposide

• Extranodal NK/T-cell lymphoma (ENKTL)

TAC:

Docetaxel, Doxorubicin (Adriamycin), Cyclophosphamide

• Breast cancer

TCHP:

Docetaxel, Carboplatin, Trastuzumab (Herceptin), Pertuzumab

• Breast cancer

TIP:

Paclitaxel, Ifosfamide, Cisplatin

• Testicular cancer

• Cervical cancer

• Transitional cell carcinoma /Urothelial cancer

TPF:

Docetaxel, Cisplatin, 5-Fluorouracil

• SCC of head and neck cancers

VAIA:

Vincristine, Dactinomycin (Actinomycin D), Ifosfamide, Doxorubicin (Actinomycin)

• Ewing sarcoma

• Rhabdomyosarcoma

VDC/IE:

Vincristine, Doxorubicin (Adriamycin), Cyclophosphamide alternating with Ifosfamide and Etoposide

• Ewing sarcoma

VeIP:

Vinblastine, Etoposide, Ifosfamide, Cisplatin

• Testicular cancer

VIDE:

Vincristine, Ifosfamide, Doxorubicin, Etoposide

• Ewing sarcoma

VR-CAP:

Bortezomib (Velcade), Rituximab, Cyclophosphamide, Doxorubicin (Adriamycin), Prednisone

• Mantle Cell lymphoma

IN PROGRESS..!